Aris Water Solutions (NYSE:ARIS) Hits New 52-Week High at $17.95

Bank of America Cuts Immunovant (NASDAQ:IMVT) Price Target to $45.00



Bank of America reduced their target price on Immunovant from $48.00 to $45.00 and set a “buy” rating on the stock in a research report on Wednesday.



Source link

Similar Posts

Leave a Reply

Your email address will not be published. Required fields are marked *